Works matching IS 17762596 AND DT 2020 AND VI 15 AND IP 5

Results: 12

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 613, doi. 10.1007/s11523-020-00754-6

By:

Sepúlveda-Sánchez, Juan Manuel;
Gil-Gil, Miguel;
Alonso-García, Miriam;
Vaz Salgado, María Ángeles;
Vicente, Elena;
Mesía Barroso, Carlos;
Rodríguez Sánchez, Ángel;
Durán, Gema;
De Las Peñas, Ramón;
Muñoz-Langa, José;
Velasco, Guillermo;
Hernández-Laín, Aurelio;
Hilario, Amaya;
Navarro Martín, Miguel;
Benavides, Manuel;
Oleaga, Laura;
Cantero Montenegro, Diana;
Ruano, Yolanda;
Sánchez-Gómez, Pilar;
Martín-Soberón, María Cruz

Publication type:

Article

Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 635, doi. 10.1007/s11523-020-00759-1

By:

Fujiwara, Motohiro;
Yuasa, Takeshi;
Komai, Yoshinobu;
Numao, Noboru;
Yamamoto, Shinya;
Fukui, Iwao;
Yonese, Junji

Publication type:

Article

Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 673, doi. 10.1007/s11523-020-00744-8

By:

Buchler, Tomas;
Kopecka, Marie;
Zemankova, Anezka;
Wiesnerová, Markéta;
Streckova, Eva;
Rozsypalova, Aneta;
Melichar, Bohuslav;
Poprach, Alexandr;
Richter, Igor

Publication type:

Article

Targeting TAM to Tame Pancreatic Cancer.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 579, doi. 10.1007/s11523-020-00751-9

By:

von Itzstein, Mitchell S.;
Burke, Michael C.;
Brekken, Rolf A.;
Aguilera, Todd A.;
Zeh, Herbert J.;
Beg, Muhammad Shaalan

Publication type:

Article

Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 623, doi. 10.1007/s11523-020-00750-w

By:

Izawa, Naoki;
Shitara, Kohei;
Yonesaka, Kimio;
Yamanaka, Takeharu;
Yoshino, Takayuki;
Sunakawa, Yu;
Masuishi, Toshiki;
Denda, Tadamichi;
Yamazaki, Kentaro;
Moriwaki, Toshikazu;
Okuda, Hiroyuki;
Kondoh, Chihiro;
Nishina, Tomohiro;
Makiyama, Akitaka;
Baba, Hideo;
Yamaguchi, Hironori;
Nakamura, Masato;
Hyodo, Ichinosuke;
Muro, Kei;
Nakajima, Takako Eguchi

Publication type:

Article

Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 681, doi. 10.1007/s11523-020-00749-3

By:

Kang, Connie;
Blair, Hannah A.

Publication type:

Article

Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 645, doi. 10.1007/s11523-020-00755-5

By:

Choi, Jung Kyu;
Cho, Heeyeong;
Moon, Byoung-San

Publication type:

Article

Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 599, doi. 10.1007/s11523-020-00748-4

By:

Niederwieser, Dietger;
Hamm, Caroline;
Cobb, Patrick;
Mo, Mindy;
Forsyth, Cecily;
Tucci, Alessandra;
Hanes, Vladimir;
Delwail, Vincent;
Hajek, Roman;
Chien, David

Publication type:

Article

Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 567, doi. 10.1007/s11523-020-00747-5

By:

Johnson, Benny;
Kopetz, Scott

Publication type:

Article

Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 589, doi. 10.1007/s11523-020-00745-7

By:

Vuong, Huy Gia;
Nguyen, Thu Quynh;
Nguyen, Hoang Cong;
Nguyen, Phuoc Truong;
Ho, An Thi Nhat;
Hassell, Lewis

Publication type:

Article

Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.

Published in:

2020

By:

Iacovelli, Roberto;
Ciccarese, Chiara;
Facchini, Gaetano;
Milella, Michele;
Urbano, Federica;
Basso, Umberto;
De Giorgi, Ugo;
Sabbatini, Roberto;
Santini, Daniele;
Berardi, Rossana;
Santoni, Matteo;
Bracarda, Sergio;
Massari, Francesco;
Masini, Cristina;
De Tursi, Michele;
Ricotta, Riccardo;
Buti, Sebastiano;
Zustovich, Fable;
Sepe, Pierangela;
Rossetti, Sabrina

Publication type:

Correction Notice

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.

Published in:

Targeted Oncology, 2020, v. 15, n. 5, p. 659, doi. 10.1007/s11523-020-00741-x

By:

Tusa, Ignazia;
Cheloni, Giulia;
Poteti, Martina;
Silvano, Angela;
Tubita, Alessandro;
Lombardi, Zoe;
Gozzini, Antonella;
Caporale, Roberto;
Scappini, Barbara;
Dello Sbarba, Persio;
Rovida, Elisabetta

Publication type:

Article